Dignitana AB (publ) (DIGN.ST)
SEK 0.92
(-2.65%)
SEK 0.92
(-2.65%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 44.83 Million SEK | -23.43% |
| 2022 | 58.55 Million SEK | -17.94% |
| 2021 | 71.35 Million SEK | -48.25% |
| 2020 | 137.88 Million SEK | 69.21% |
| 2019 | 81.48 Million SEK | 1.39% |
| 2018 | 80.37 Million SEK | -2.34% |
| 2017 | 82.29 Million SEK | 28.92% |
| 2016 | 63.83 Million SEK | 33.99% |
| 2015 | 47.64 Million SEK | 125.54% |
| 2014 | 21.12 Million SEK | -39.73% |
| 2013 | 35.04 Million SEK | 1.01% |
| 2012 | 34.69 Million SEK | 127.52% |
| 2011 | 15.24 Million SEK | -27.53% |
| 2010 | 21.04 Million SEK | 23.89% |
| 2009 | 16.98 Million SEK | 14.26% |
| 2008 | 14.86 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 44.73 Million SEK | -0.22% |
| 2024 Q2 | 48.44 Million SEK | 8.29% |
| 2023 Q1 | 58.48 Million SEK | -0.11% |
| 2023 Q3 | 48.37 Million SEK | -4.86% |
| 2023 FY | 44.83 Million SEK | -23.43% |
| 2023 Q4 | 44.83 Million SEK | -7.32% |
| 2023 Q2 | 50.84 Million SEK | -13.07% |
| 2022 Q2 | 64.73 Million SEK | -0.64% |
| 2022 FY | 58.55 Million SEK | -17.94% |
| 2022 Q4 | 58.55 Million SEK | -8.7% |
| 2022 Q1 | 65.15 Million SEK | -8.69% |
| 2022 Q3 | 64.12 Million SEK | -0.94% |
| 2021 Q3 | 80.62 Million SEK | -14.15% |
| 2021 FY | 71.35 Million SEK | -48.25% |
| 2021 Q1 | 102.43 Million SEK | -25.71% |
| 2021 Q2 | 93.91 Million SEK | -8.32% |
| 2021 Q4 | 71.35 Million SEK | -11.5% |
| 2020 Q3 | 80.93 Million SEK | 10.43% |
| 2020 Q4 | 137.88 Million SEK | 70.36% |
| 2020 Q2 | 73.29 Million SEK | -1.73% |
| 2020 Q1 | 74.58 Million SEK | -8.48% |
| 2020 FY | 137.88 Million SEK | 69.21% |
| 2019 Q3 | 95.54 Million SEK | 54.21% |
| 2019 FY | 81.48 Million SEK | 1.39% |
| 2019 Q1 | 71.46 Million SEK | -11.08% |
| 2019 Q2 | 61.95 Million SEK | -13.3% |
| 2019 Q4 | 81.48 Million SEK | -14.71% |
| 2018 Q4 | 80.37 Million SEK | 58.84% |
| 2018 FY | 80.37 Million SEK | -2.34% |
| 2018 Q3 | 50.6 Million SEK | -3.37% |
| 2018 Q2 | 52.36 Million SEK | -10.06% |
| 2018 Q1 | 58.22 Million SEK | -29.25% |
| 2017 Q3 | 45.13 Million SEK | -8.12% |
| 2017 Q2 | 49.12 Million SEK | -11.65% |
| 2017 Q1 | 55.6 Million SEK | -12.89% |
| 2017 FY | 82.29 Million SEK | 28.92% |
| 2017 Q4 | 82.29 Million SEK | 82.32% |
| 2016 FY | 63.83 Million SEK | 33.99% |
| 2016 Q3 | 71.15 Million SEK | -12.28% |
| 2016 Q4 | 63.83 Million SEK | -10.29% |
| 2016 Q2 | 81.11 Million SEK | 109.25% |
| 2016 Q1 | 38.76 Million SEK | -18.63% |
| 2015 Q2 | 26.05 Million SEK | -14.38% |
| 2015 FY | 47.64 Million SEK | 125.54% |
| 2015 Q4 | 47.64 Million SEK | -9.43% |
| 2015 Q3 | 52.6 Million SEK | 101.86% |
| 2015 Q1 | 30.43 Million SEK | 44.08% |
| 2014 Q1 | 25.72 Million SEK | -26.61% |
| 2014 FY | 21.12 Million SEK | -39.73% |
| 2014 Q2 | 22.98 Million SEK | -10.64% |
| 2014 Q4 | 21.12 Million SEK | 1.69% |
| 2014 Q3 | 20.77 Million SEK | -9.63% |
| 2013 Q3 | 38.07 Million SEK | 51.19% |
| 2013 Q2 | 25.18 Million SEK | -15.16% |
| 2013 FY | 35.04 Million SEK | 1.01% |
| 2013 Q4 | 35.04 Million SEK | -7.96% |
| 2013 Q1 | 29.68 Million SEK | -14.45% |
| 2012 Q3 | 18.41 Million SEK | 26.43% |
| 2012 Q1 | 23.85 Million SEK | 56.45% |
| 2012 Q2 | 14.56 Million SEK | -38.95% |
| 2012 Q4 | 34.69 Million SEK | 88.41% |
| 2012 FY | 34.69 Million SEK | 127.52% |
| 2011 Q3 | 21.88 Million SEK | -26.95% |
| 2011 Q4 | 15.24 Million SEK | -30.33% |
| 2011 Q2 | 29.96 Million SEK | 89.03% |
| 2011 FY | 15.24 Million SEK | -27.53% |
| 2011 Q1 | 15.85 Million SEK | -24.67% |
| 2010 Q4 | 21.04 Million SEK | 16.29% |
| 2010 Q3 | 18.09 Million SEK | -5.83% |
| 2010 FY | 21.04 Million SEK | 23.89% |
| 2010 Q1 | 20.06 Million SEK | 18.16% |
| 2010 Q2 | 19.21 Million SEK | -4.25% |
| 2009 Q3 | 18.17 Million SEK | -2.42% |
| 2009 FY | 16.98 Million SEK | 14.26% |
| 2009 Q2 | 18.63 Million SEK | 0.0% |
| 2009 Q4 | 16.98 Million SEK | -6.58% |
| 2008 FY | 14.86 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acarix AB (publ) | 62.88 Million SEK | 28.708% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 98.636% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 98.636% |
| Arcoma AB | 81.96 Million SEK | 45.303% |
| Bactiguard Holding AB (publ) | 682.87 Million SEK | 93.435% |
| BICO Group AB (publ) | 10.19 Billion SEK | 99.56% |
| Boule Diagnostics AB (publ) | 755.1 Million SEK | 94.063% |
| CellaVision AB (publ) | 928.71 Million SEK | 95.173% |
| Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | 22.337% |
| Chordate Medical Holding AB (publ) | 21.95 Million SEK | -104.19% |
| C-Rad AB (publ) | 404 Million SEK | 88.903% |
| Duearity AB (publ) | 15.14 Million SEK | -196.031% |
| Episurf Medical AB (publ) | 104.3 Million SEK | 57.017% |
| Getinge AB (publ) | 55.09 Billion SEK | 99.919% |
| Scandinavian Real Heart AB (Publ) | 102.63 Million SEK | 56.321% |
| Iconovo AB (publ) | 128.07 Million SEK | 64.998% |
| Integrum AB (publ) | 164.85 Million SEK | 72.806% |
| Luxbright AB (publ) | 40.68 Million SEK | -10.186% |
| Mentice AB (publ) | 322.52 Million SEK | 86.1% |
| OssDsign AB (publ) | 356.38 Million SEK | 87.421% |
| Paxman AB (publ) | 167.12 Million SEK | 73.175% |
| Promimic AB (publ) | 92.87 Million SEK | 51.73% |
| Qlife Holding AB (publ) | 39.04 Million SEK | -14.816% |
| SciBase Holding AB (publ) | 64.33 Million SEK | 30.315% |
| ScandiDos AB (publ) | 81.47 Million SEK | 44.974% |
| Sectra AB (publ) | 3.21 Billion SEK | 98.604% |
| Sedana Medical AB (publ) | 1.01 Billion SEK | 95.579% |
| Senzime AB (publ) | 433.54 Million SEK | 89.659% |
| SpectraCure AB (publ) | 144.83 Million SEK | 69.047% |
| Stille AB | 804.89 Million SEK | 94.43% |
| Vitrolife AB (publ) | 16.39 Billion SEK | 99.726% |
| Xvivo Perfusion AB (publ) | 2.19 Billion SEK | 97.958% |